{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T17:17:34Z","timestamp":1776878254310,"version":"3.51.2"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Science and Technology Joint construction Project of Henan Province","award":["LHGJ20210443"],"award-info":[{"award-number":["LHGJ20210443"]}]},{"name":"Provincial-Ministerial Jointly Supported Youth Project of the Henan Medical Science and Technology Research Program","award":["SBGJ202403037"],"award-info":[{"award-number":["SBGJ202403037"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-03008-x","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:12:53Z","timestamp":1766412773000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Molecular mechanism of RBM15-mediated m6A modification in hepatitis B virus replication"],"prefix":"10.1186","volume":"22","author":[{"given":"Min","family":"Ni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengju","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"3008_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1018053","volume":"13","author":"Z Yang","year":"2022","unstructured":"Yang Z, Sun B, Xiang J, Wu H, Kan S, Hao M, et al. Role of epigenetic modification in interferon treatment of hepatitis B virus infection. Front Immunol. 2022;13:1018053. https:\/\/doi.org\/10.3389\/fimmu.2022.1018053.","journal-title":"Front Immunol"},{"issue":"2","key":"3008_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/cei.13614","volume":"205","author":"T Cargill","year":"2021","unstructured":"Cargill T, Barnes E. Therapeutic vaccination for treatment of chronic hepatitis B. Clin Exp Immunol. 2021;205(2):106\u201318. https:\/\/doi.org\/10.1111\/cei.13614.","journal-title":"Clin Exp Immunol"},{"key":"3008_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1075916","volume":"13","author":"JR Zheng","year":"2022","unstructured":"Zheng JR, Wang ZL, Feng B. Hepatitis B functional cure and immune response. Front Immunol. 2022;13:1075916. https:\/\/doi.org\/10.3389\/fimmu.2022.1075916.","journal-title":"Front Immunol"},{"issue":"4","key":"3008_CR4","doi-asserted-by":"publisher","first-page":"391","DOI":"10.33073\/pjm-2020-044","volume":"69","author":"M Guvenir","year":"2020","unstructured":"Guvenir M, Arikan A. Hepatitis B virus: from diagnosis to treatment. Pol J Microbiol. 2020;69(4):391\u20139. https:\/\/doi.org\/10.33073\/pjm-2020-044.","journal-title":"Pol J Microbiol"},{"key":"3008_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens13040291","author":"V Soriano","year":"2024","unstructured":"Soriano V, Moreno-Torres V, Trevino A, de Jesus F, Corral O, de Mendoza C. Prospects for controlling hepatitis B globally. Pathogens. 2024. https:\/\/doi.org\/10.3390\/pathogens13040291.","journal-title":"Pathogens"},{"issue":"1","key":"3008_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-025-02644-7","volume":"16","author":"W Shen","year":"2025","unstructured":"Shen W, Ma Y, Yang C, Yan S, Ye K. Role of N6-methyladenosine methyltransferase component RBM15 in cancer progression and its therapeutic potential. Discover Oncol. 2025;16(1):855. https:\/\/doi.org\/10.1007\/s12672-025-02644-7.","journal-title":"Discover Oncol"},{"issue":"1","key":"3008_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3724\/abbs.2024152","volume":"57","author":"T Deng","year":"2024","unstructured":"Deng T, Ma J. Structures and mechanisms of the RNA m(6)A writer. Acta Biochim Biophys Sin. 2024;57(1):59\u201372. https:\/\/doi.org\/10.3724\/abbs.2024152.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"1","key":"3008_CR8","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1080\/22221751.2021.2006580","volume":"10","author":"A Kostyusheva","year":"2021","unstructured":"Kostyusheva A, Brezgin S, Glebe D, Kostyushev D, Chulanov V. Host-cell interactions in HBV infection and pathogenesis: the emerging role of m6A modification. Emerg Microbes Infect. 2021;10(1):2264\u201375. https:\/\/doi.org\/10.1080\/22221751.2021.2006580.","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"3008_CR9","doi-asserted-by":"publisher","DOI":"10.31083\/FBL36291","volume":"30","author":"J Zhang","year":"2025","unstructured":"Zhang J, Yu L, Wu X, Pan W. Small extracellular vesicles promote HBV replication via METTL3-IGF2BP2-mediated m6A modification. Front Biosci (Landmark Ed). 2025;30(3):36291. https:\/\/doi.org\/10.31083\/FBL36291.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"2","key":"3008_CR10","doi-asserted-by":"publisher","first-page":"233","DOI":"10.4014\/jmb.2309.09013","volume":"34","author":"JS Moon","year":"2024","unstructured":"Moon JS, Lee W, Cho YH, Kim Y, Kim GW. The significance of N6-methyladenosine RNA methylation in regulating the hepatitis B virus life cycle. J Microbiol Biotechnol. 2024;34(2):233\u20139. https:\/\/doi.org\/10.4014\/jmb.2309.09013.","journal-title":"J Microbiol Biotechnol"},{"issue":"1","key":"3008_CR11","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s10020-020-00185-z","volume":"26","author":"Q Fang","year":"2020","unstructured":"Fang Q, Chen H. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma. Mol Med. 2020;26(1):60. https:\/\/doi.org\/10.1186\/s10020-020-00185-z.","journal-title":"Mol Med"},{"issue":"11","key":"3008_CR12","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/s12276-023-01108-8","volume":"55","author":"J Yu","year":"2023","unstructured":"Yu J, Li W, Hou GJ, Sun DP, Yang Y, Yuan SX, et al. Circular RNA cfam210a, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. Exp Mol Med. 2023;55(11):2390\u2013401. https:\/\/doi.org\/10.1038\/s12276-023-01108-8.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3008_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011917","volume":"20","author":"S Tsukuda","year":"2024","unstructured":"Tsukuda S, Harris JM, Magri A, Balfe P, Siddiqui A, Wing PAC, et al. The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. PLoS Pathog. 2024;20(1):e1011917. https:\/\/doi.org\/10.1371\/journal.ppat.1011917.","journal-title":"PLoS Pathog"},{"issue":"2","key":"3008_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008338","volume":"16","author":"H Imam","year":"2020","unstructured":"Imam H, Kim GW, Mir SA, Khan M, Siddiqui A. Interferon-stimulated gene 20 (ISG20) selectively degrades N6-methyladenosine modified Hepatitis B Virus transcripts. PLoS Pathog. 2020;16(2):e1008338. https:\/\/doi.org\/10.1371\/journal.ppat.1008338.","journal-title":"PLoS Pathog"},{"issue":"4","key":"3008_CR15","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s10735-025-10551-y","volume":"56","author":"Y Fang","year":"2025","unstructured":"Fang Y, Shi X, Ge J. Mechanism of METTL14 regulates HBV-HCC malignant progression by mediating m6A modification of FOXP3 and thus transcriptional activation of ALDOB. J Mol Histol. 2025;56(4):259. https:\/\/doi.org\/10.1007\/s10735-025-10551-y.","journal-title":"J Mol Histol"},{"key":"3008_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/wrna.1661","author":"S Jantrapirom","year":"2021","unstructured":"Jantrapirom S, Koonrungsesomboon N, Yoshida H, Candeias M, Pruksakorn D, Piccolo L. Long noncoding RNA-dependent methylation of nonhistone proteins. Wiley Interdiscip Rev RNA. 2021. https:\/\/doi.org\/10.1002\/wrna.1661.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"3008_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13133115","author":"V Alfano","year":"2021","unstructured":"Alfano V, Zeisel MB, Levrero M, Guerrieri F. The lncRNAs in HBV-related HCCs: targeting chromatin dynamics and beyond. Cancers (Basel). 2021. https:\/\/doi.org\/10.3390\/cancers13133115.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"3008_CR18","doi-asserted-by":"publisher","first-page":"7901","DOI":"10.1007\/s11033-021-06818-8","volume":"48","author":"SM Shahen","year":"2021","unstructured":"Shahen SM, Elshenawy SZ, Mohamed SE, Talaat RM. Genetic polymorphisms in the miR-372 (rs12983273) and LncRNA HULC (rs7763881) genes and susceptibility to Hepatitis B virus (HBV) infection. Mol Biol Rep. 2021;48(12):7901\u20136. https:\/\/doi.org\/10.1007\/s11033-021-06818-8.","journal-title":"Mol Biol Rep"},{"issue":"7","key":"3008_CR19","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1007\/s12094-023-03109-5","volume":"25","author":"Q Ma","year":"2023","unstructured":"Ma Q, Lu Q, Lei X, Zhao J, Sun W, Huang D, et al. Relationship between HuR and tumor drug resistance. Clin Transl Oncol. 2023;25(7):1999\u20132014. https:\/\/doi.org\/10.1007\/s12094-023-03109-5.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"3008_CR20","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/s41392-020-00384-4","volume":"6","author":"N Wang","year":"2021","unstructured":"Wang N, Wu R, Tang D, Kang R. The BET family in immunity and disease. Signal Transduct Target Ther. 2021;6(1):23. https:\/\/doi.org\/10.1038\/s41392-020-00384-4.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"3008_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202100180","volume":"43","author":"Y Liang","year":"2021","unstructured":"Liang Y, Tian J, Wu T. BRD4 in physiology and pathology: \u201cBET\u201d on its partners. BioEssays. 2021;43(12):e2100180. https:\/\/doi.org\/10.1002\/bies.202100180.","journal-title":"BioEssays"},{"key":"3008_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/v14102274","author":"IP Chen","year":"2022","unstructured":"Chen IP, Ott M. Viral hijacking of BET proteins. Viruses. 2022. https:\/\/doi.org\/10.3390\/v14102274.","journal-title":"Viruses"},{"key":"3008_CR23","unstructured":"Guide for the Care and Use of Laboratory Animals. The National Academies Collection: Reports funded by National Institutes of Health. 8th ed. Washington (DC)2011."},{"issue":"4","key":"3008_CR24","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138. https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"8","key":"3008_CR25","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/jvh.13710","volume":"29","author":"L Chen","year":"2022","unstructured":"Chen L, Zhu L, Lu X, Ming X, Yang B. TRPM2 regulates autophagy to participate in hepatitis B virus replication. J Viral Hepat. 2022;29(8):627\u201336. https:\/\/doi.org\/10.1111\/jvh.13710.","journal-title":"J Viral Hepat"},{"key":"3008_CR26","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1248","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. starBase v20: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014. https:\/\/doi.org\/10.1093\/nar\/gkt1248.","journal-title":"Nucleic Acids Res"},{"key":"3008_CR27","doi-asserted-by":"publisher","DOI":"10.3892\/or.2024.8801","author":"N Zhang","year":"2024","unstructured":"Zhang N, Wen K. The role of lncRNA binding to RNA-binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review). Oncol Rep. 2024. https:\/\/doi.org\/10.3892\/or.2024.8801.","journal-title":"Oncol Rep"},{"issue":"3","key":"3008_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.cnc.2022.04.012","volume":"34","author":"N Ledoux","year":"2022","unstructured":"Ledoux N. Hepatitis B and acute liver failure. Crit Care Nurs Clin North Am. 2022;34(3):259\u201365. https:\/\/doi.org\/10.1016\/j.cnc.2022.04.012.","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"2","key":"3008_CR29","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3350\/cmh.2023.0412","volume":"30","author":"S Shan","year":"2024","unstructured":"Shan S, Zhao X, Jia J. Comprehensive approach to controlling chronic hepatitis B in China. Clin Mol Hepatol. 2024;30(2):135\u201343. https:\/\/doi.org\/10.3350\/cmh.2023.0412.","journal-title":"Clin Mol Hepatol"},{"issue":"1","key":"3008_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/21505594.2022.2028483","volume":"13","author":"YC Chuang","year":"2022","unstructured":"Chuang YC, Tsai KN, Ou JJ. Pathogenicity and virulence of hepatitis B virus. Virulence. 2022;13(1):258\u201396. https:\/\/doi.org\/10.1080\/21505594.2022.2028483.","journal-title":"Virulence"},{"key":"3008_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010213","author":"HW Lee","year":"2020","unstructured":"Lee HW, Lee JS, Ahn SH. Hepatitis B virus cure: targets and future therapies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010213.","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3008_CR32","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1007\/s10753-023-01841-2","volume":"46","author":"D Li","year":"2023","unstructured":"Li D, Liu Y, Zhou J, Chen Y, Yang C, Liu H, et al. M6A regulator-mediated RNA methylation modulates immune microenvironment of hepatitis B virus-related acute liver failure. Inflammation. 2023;46(5):1777\u201395. https:\/\/doi.org\/10.1007\/s10753-023-01841-2.","journal-title":"Inflammation"},{"key":"3008_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.821710","volume":"9","author":"T Zhao","year":"2022","unstructured":"Zhao T, Qi J, Liu T, Wu H, Zhu Q. N6-methyladenosine modification participates in the progression of hepatitis B virus-related liver fibrosis by regulating immune cell infiltration. Front Med (Lausanne). 2022;9:821710. https:\/\/doi.org\/10.3389\/fmed.2022.821710.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"3008_CR34","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1111\/jgh.15999","volume":"37","author":"C Zhang","year":"2022","unstructured":"Zhang C, Dai D, Zhang W, Yang W, Guo Y, Wei Q. Role of m6A RNA methylation in the development of hepatitis B virus-associated hepatocellular carcinoma. J Gastroenterol Hepatol. 2022;37(11):2039\u201350. https:\/\/doi.org\/10.1111\/jgh.15999.","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"3008_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41392-023-01316-8","volume":"8","author":"Y Yang","year":"2023","unstructured":"Yang Y, Yan Y, Yin J, Tang N, Wang K, Huang L, et al. O-GlcNAcylation of YTHDF2 promotes HBV-related hepatocellular carcinoma progression in an N(6)-methyladenosine-dependent manner. Signal Transduct Target Ther. 2023;8(1):63. https:\/\/doi.org\/10.1038\/s41392-023-01316-8.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3008_CR36","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/s41420-021-00703-w","volume":"7","author":"X Cai","year":"2021","unstructured":"Cai X, Chen Y, Man D, Yang B, Feng X, Zhang D, et al. RBM15 promotes hepatocellular carcinoma progression by regulating N6-methyladenosine modification of YES1 mRNA in an IGF2BP1-dependent manner. Cell Death Discov. 2021;7(1):315. https:\/\/doi.org\/10.1038\/s41420-021-00703-w.","journal-title":"Cell Death Discov"},{"issue":"11","key":"3008_CR37","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1002\/mc.23802","volume":"63","author":"X Xu","year":"2024","unstructured":"Xu X, Wu S, Zhang Y, Fan W, Lin X, Chen K. M6A modification of VEGFA mRNA by RBM15\/YTHDF2\/IGF2BP3 contributes to angiogenesis of hepatocellular carcinoma. Mol Carcinog. 2024;63(11):2174\u201389. https:\/\/doi.org\/10.1002\/mc.23802.","journal-title":"Mol Carcinog"},{"key":"3008_CR38","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2022.3438","author":"M Cao","year":"2022","unstructured":"Cao M, Yuan D, Jiang H, Zhou G, Chen C, Han G. Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication in vitro by reinforcing miR-192\u20135p\/ATG7-induced autophagy. Eur J Histochem. 2022. https:\/\/doi.org\/10.4081\/ejh.2022.3438.","journal-title":"Eur J Histochem"},{"issue":"22","key":"3008_CR39","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1042\/CS20200970","volume":"134","author":"F Ren","year":"2020","unstructured":"Ren F, Ren JH, Song CL, Tan M, Yu HB, Zhou YJ, et al. LncRNA HOTAIR modulates hepatitis B virus transcription and replication by enhancing SP1 transcription factor. Clin Sci Lond. 2020;134(22):3007\u201322. https:\/\/doi.org\/10.1042\/CS20200970.","journal-title":"Clin Sci Lond"},{"issue":"1","key":"3008_CR40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12985-021-01596-y","volume":"18","author":"Q Hao","year":"2021","unstructured":"Hao Q, Wang Z, Wang Q, Chen B, Qian H, Liu X, et al. Identification and characterization of lncRNA AP000253 in occult hepatitis B virus infection. Virol J. 2021;18(1):125. https:\/\/doi.org\/10.1186\/s12985-021-01596-y.","journal-title":"Virol J"},{"key":"3008_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.834650","volume":"13","author":"N Samudh","year":"2022","unstructured":"Samudh N, Shrilall C, Arbuthnot P, Bloom K, Ely A. Diversity of dysregulated long non-coding RNAs in HBV-related hepatocellular carcinoma. Front Immunol. 2022;13:834650. https:\/\/doi.org\/10.3389\/fimmu.2022.834650.","journal-title":"Front Immunol"},{"issue":"25","key":"3008_CR42","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.3748\/wjg.v28.i25.2823","volume":"28","author":"HC Li","year":"2022","unstructured":"Li HC, Yang CH, Lo SY. Long noncoding RNAs in hepatitis B virus replication and oncogenesis. World J Gastroenterol. 2022;28(25):2823\u201342. https:\/\/doi.org\/10.3748\/wjg.v28.i25.2823.","journal-title":"World J Gastroenterol"},{"key":"3008_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115497","volume":"210","author":"M Cheng","year":"2023","unstructured":"Cheng M, Li JJ, Niu XN, Zhu L, Liu JY, Jia PC, et al. BRD4 promotes hepatic stellate cells activation and hepatic fibrosis via mediating P300\/H3K27ac\/PLK1 axis. Biochem Pharmacol. 2023;210:115497. https:\/\/doi.org\/10.1016\/j.bcp.2023.115497.","journal-title":"Biochem Pharmacol"},{"issue":"16","key":"3008_CR44","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.1002\/cam4.4094","volume":"10","author":"KT Chuang","year":"2021","unstructured":"Chuang KT, Wang SN, Hsu SH, Wang LT. Impact of bromodomain-containing protein 4 (BRD4) and intestine-specific homeobox (ISX) expression on the prognosis of patients with hepatocellular carcinoma\u2019 for better clarity. Cancer Med. 2021;10(16):5545\u201356. https:\/\/doi.org\/10.1002\/cam4.4094.","journal-title":"Cancer Med"},{"issue":"1","key":"3008_CR45","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s10753-020-01321-x","volume":"44","author":"C Shen","year":"2021","unstructured":"Shen C, Li J. LncRNA XIST silencing protects against sepsis-induced acute liver injury via inhibition of BRD4 expression. Inflammation. 2021;44(1):194\u2013205. https:\/\/doi.org\/10.1007\/s10753-020-01321-x.","journal-title":"Inflammation"},{"issue":"11","key":"3008_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2024.102134","volume":"104","author":"JY Liu","year":"2024","unstructured":"Liu JY, Liu ZL, Yang M, Du CL, Zhu Y, Sun LJ, et al. Involvement of BRD4 in alcoholic liver injury: autophagy modulation via regulation of the SIRT1\/Beclin1 axis. Lab Invest. 2024;104(11):102134. https:\/\/doi.org\/10.1016\/j.labinv.2024.102134.","journal-title":"Lab Invest"},{"key":"3008_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.683506","volume":"8","author":"C Wu","year":"2021","unstructured":"Wu C, Cheng D, Peng Y, Li Y, Fu C, Wang Y, et al. Hepatic BRD4 is upregulated in liver fibrosis of various etiologies and positively correlated to fibrotic severity. Front Med. 2021;8:683506. https:\/\/doi.org\/10.3389\/fmed.2021.683506.","journal-title":"Front Med"},{"key":"3008_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2023.105552","volume":"211","author":"X Yu","year":"2023","unstructured":"Yu X, Long Q, Shen S, Liu Z, Chandran J, Zhang J, et al. Screening of an epigenetic compound library identifies BRD4 as a potential antiviral target for hepatitis B virus covalently closed circular DNA transcription. Antiviral Res. 2023;211:105552. https:\/\/doi.org\/10.1016\/j.antiviral.2023.105552.","journal-title":"Antiviral Res"},{"key":"3008_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/biom15010062","author":"A Boonstra","year":"2025","unstructured":"Boonstra A, Sari G. HBV cccDNA: the molecular reservoir of hepatitis B persistence and challenges to achieve viral eradication. Biomolecules. 2025. https:\/\/doi.org\/10.3390\/biom15010062.","journal-title":"Biomolecules"},{"issue":"1","key":"3008_CR50","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.virs.2023.10.002","volume":"39","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li Y, Huan C, Hou Y, Liu R, Shi H, et al. LncRNA NKILA inhibits HBV replication by repressing NF-kappaB signalling activation. Virol Sin. 2024;39(1):44\u201355. https:\/\/doi.org\/10.1016\/j.virs.2023.10.002.","journal-title":"Virol Sin"},{"key":"3008_CR51","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/1471-2407-14-721","volume":"14","author":"M Bandopadhyay","year":"2014","unstructured":"Bandopadhyay M, Banerjee A, Sarkar N, Panigrahi R, Datta S, Pal A, et al. Tumor suppressor micro RNA miR-145 and onco micro RNAs miR-21 and miR-222 expressions are differentially modulated by hepatitis B virus X protein in malignant hepatocytes. BMC Cancer. 2014;14:721. https:\/\/doi.org\/10.1186\/1471-2407-14-721.","journal-title":"BMC Cancer"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-03008-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-03008-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T02:02:43Z","timestamp":1766455363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12985-025-03008-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3008"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-03008-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The entire animal experiments were ethically approved by the Animal Ethics Committee of Third Affiliated Hospital of Zhengzhou University and conducted strictly in accordance with the\n                      Guidelines for the Care and Use of Laboratory Animals\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}